Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: 4D Pharma, Algernon, Alphamab Oncology, Eagle, Everest Medicines, Humanigen, Hutchison China Meditech, Mayne Pharma, Mithra, Redhill, Remegen, Sinovac, SLA Pharma, The KD Pharma Group, Zai Lab.